Company Spotlight

Adare Pharmaceuticals

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile

Aphena Pharma Solutions, Inc.

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile


Contract Service Directory


CMIC CMO USA Corp.





Company Headquarters

Cedar Brook Corporate Center
3 Cedar Brook Drive
Cranbury, NJ 08512
United States

Other Locations

Cedar Brook Corporate Center
3 Cedar Brook Drive
Cranbury, NJ 08512
United States

Company Description

CMIC CMO USA Corporation is a member of the CMIC Group, Japan's first and largest clinical CRO with full services from preclinical to clinical, drug development, manufacturing, sales and post market. CMIC Group has facilities in US, Japan and Asia and over 7000 employees worldwide. Our FDA-registered facility is located near Princeton, New Jersey. We specialize in the formulation development and GMP commercial manufacturing of NDA and ANDA solid dosage products with expertise in sustained and controlled release products. We will guide you towards regulatory approval and commercial launch while also helping you reduce your development cycles and capital costs.

Contract Service Directory

    Related Content

    • Biologics, Proteins, Vaccines | CRO News | Drug Discovery | Preclinical Outsourcing
      Charles River to Acquire HemaCare Corp. for $380M

      Charles River to Acquire HemaCare Corp. for $380M

      Expands scientific capabilities for cell and gene therapies
      12.16.19

    • Breaking News | CRO News | Promotions & Moves
      Parexel Adds Experts to Regulatory Consulting Group

      Parexel Adds Experts to Regulatory Consulting Group

      Four new hires from U.S. FDA and MHRA will serve as technical vice presidents
      12.10.19

    • Breaking News | Collaborations & Alliances
      Appili, Saptalis Enter Commercial Pact

      Appili, Saptalis Enter Commercial Pact

      Saptalis to oversee the regulatory review, manufacturing and preparation for the anticipated commercialization of ATI-1501 in the U.S.
      12.03.19


    • cGMP Manufacture | Facilities
      Transitioning from Clinical Production to Commercial Manufacturing

      Transitioning from Clinical Production to Commercial Manufacturing

      Cell and gene therapy facilities face a unique set of challenges as they scale towards commercial production and require equally unique solutions.
      Peter Walters, Lead Process Engineer, CRB USA 11.20.19

    • Biologics, Proteins, Vaccines | Clinical Trials
      Advanced Therapies: Adding a New Layer of Complexity to Clinical Trials

      Advanced Therapies: Adding a New Layer of Complexity to Clinical Trials

      Overcoming the challenges of a new and changing clinical trial landscape
      Erin Finot, Global Head of Immuno-Oncology, IQVIA Biotech 11.18.19

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Scale-up/Technology Transfer
      The Pain-Free Guide: Transitioning from Clinical Production to Commercial Manufacturing

      The Pain-Free Guide: Transitioning from Clinical Production to Commercial Manufacturing

      Cell and gene therapy facilities face a unique set of challenges as they scale towards commercial production and require equally unique solutions
      Peter Walters , Lead Process Engineer, CRB USA 11.11.19


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      Samsung Biologics and Ichnos Sciences Ink Mfg. Deal

      Samsung Biologics and Ichnos Sciences Ink Mfg. Deal

      Samsung to manufacture drug substance for ISB 830 Phase 3 clinical trials and for potential future global commercial supply upon regulatory approval.
      11.05.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Europe to Surpass U.S. Biologic Manufacturing Capacity by 2023

      Europe to Surpass U.S. Biologic Manufacturing Capacity by 2023

      CPhI Annual Report says demand for biological manufacturing is growing faster than capacity growth.
      11.04.19

    • Bio News | Bioanalytical Services | Breaking News | Industry News
      Sartorius to Acquire Danaher Life Science Platform Businesses

      Sartorius to Acquire Danaher Life Science Platform Businesses

      Complements positions in bioanalytics and bioprocessing segments.
      11.01.19


    • APIs | cGMP Manufacture | Clinical Trial Materials | Custom Sourcing News | Industry News
      Nordic Nanovector, Isotope Technologies Enter Supply Pact

      Nordic Nanovector, Isotope Technologies Enter Supply Pact

      Extend global supply agreement for n.c.a. Lutetium-177 (EndolucinBeta)
      10.07.19

    • Contracting And Outsourcing Exhibitor List

      2019 Exhibitors Company Table 3C PACKAGING 138 Adare Pharmaceuticals 97 Adents 123 Admix Pharma Labs 135 Advanced Analytical…
      09.17.19

    • It’s Showtime!

      It’s Showtime!

      Come to New Brunswick, NJ and fulfill all your outsourcing desires!
      Tim Wright, Editor 09.16.19